$9.3M for Bluebird Bio
Bluebird bio, the gene therapy company based in Cambridge, Massachusetts, took in an award of $9.3 million for the first round of its strategic partnership with the California Institute for Regenerative Medicine.
29 October 2012•3 mins read
